Active — Not RecruitingNot Applicable

Long-Term Follow-up of Adult With Atorpphic Scars Treated With TRTP-101

South Korea3 participantsStarted 2024-09-06

Plain-language summary

CIC101-01-LT is a long-term follow-up study of subjects treated with TRTP-101 and will evaluate the long-term safety and efficacy of TRTP-101.

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Received TRTP-101 in clinical trial CIC101-01 * Provided written informed consent to participate in this study Exclusion Criteria: * Judged to be unsuitable to participate in this long-term follow-up

What they're measuring

Serious Adverse Event

Timeframe: Up to 5 years

Trial details

NCT IDNCT06435884

SponsorCellinCells

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2029-09

View on ClinicalTrials.gov More Atrophic Scar trials